Penn Medicine Provider
Hematology, Medical Oncology
David M. Mintzer, MD
4.9
(1447)
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Chief, Section of Hematology Oncology, Pennsylvania Hospital
  • Clinical Professor of Medicine (Hematology-Oncology)

Education and training

  • Medical School: Jefferson Medical College
  • Residency: Pennsylvania Hospital
  • Fellowship: Thomas Jefferson University Hospital
  • Fellowship: Memorial Sloan-Kettering Cancer Center

What my patients think about me

Average Rating
4.9

1447 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
extremely professional
May 2025
5.0
5.0
he is a great doctor
May 2025
5.0
5.0
he cares about his patients.
May 2025
5.0
5.0
very nice and knowledgeable

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Mintzer is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

David M. Mintzer But Where is My Doctor? The Increasing and Relentless Fragmentation of Oncology Care , Journal of Clinical Oncology , 41(26): 2023,4313

Mintzer D, Henry D FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies , MDEdge: 2021

Mintzer D, Henry D FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs , MDEdge: 2021

David Mintzer MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship , American College of Physicians: 2021

Deye, DL; Mintzer D MKSAP 19 Audio companion , Oakstone: 2021

Mintzer D MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship , American College of Physicians: 2021

Bryer E, Mintzer D, Henry DH 2019 At a Glance: Hem-Onc U.S. Drug Approvals , MDedge/Hematology and Oncology: 2019

Emily Bryer, Monique Neault, David Mintzer Managing Dying: Medical Care and Decision Making at the Very End-of-Life , Palliative Medicine & Care: Open Access: 2019,DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180

Bryer E, Mintzer D, Henry D 2018 At A Glance: Recently Approved Therapies in Oncology , MD Edge/Hematology and Oncology : 2019,://mdedge-files-live.s3.us-east-2.amazonaws.com

Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). , Leukemia and Lymphoma : 2019,1-4